The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Key role of mast cells and their major secretory products in inflammatory bowel disease
Open accessAbstract
Historically, mast cells were known as a key cell type involved in type I hypersensitivity. Until last two decades, this cell type was recognized to be widely involved in a number of non-allergic diseases including inflammatory bowel disease (IBD). Markedly increased numbers of mast cells were observed in the mucosa of the ileum and colon of patients with IBD, which was accompanied by great changes of the content in mast cells such as dramatically increased expression of TNFalpha, IL-16 and substance P. The evidence of mast cell degranulation was found in the wall of intestine from patients with IBD with immunohistochemistry technique. The highly elevated histamine and tryptase levels were detected in mucosa of patients with IBD, strongly suggesting that mast cell degranulation is involved in the pathogenesis of IBD. However, little is known of the actions of histamine, tryptase, chymase and carboxypeptidase in IBD. Over the last decade, heparin has been used to treat IBD in clinical practice. The low molecular weight heparin (LMWH) was effective as adjuvant therapy, and the patients showed good clinical and laboratory response with no serious adverse effects. The roles of PGD2, LTC4, PAF and mast cell cytokines in IBD were also discussed. Recently, a series of experiments with dispersed colon mast cells suggested there should be at least two pathways in man for mast cells to amplify their own activation-degranulation signals in an autocrine or paracrine manner. The hypothesis is that mast cell secretogogues induce mast cell degranulation, release histamine, then stimulate the adjacent mast cells or positively feedback to further stimulate its host mast cells through H1 receptor. Whereas released tryptase acts similarly to histamine, but activates mast cells through its receptor PAR-2. The connections between current anti-IBD therapies or potential therapies for IBD with mast cells were discussed, implicating further that mast cell is a key cell type that is involved in the pathogenesis of IBD. In conclusion, while pathogenesis of IBD remains unclear, the key role of mast cells in this group of diseases demonstrated in the current review implicates strongly that IBD is a mast cell associated disease. Therefore, close attentions should be paid to the role of mast cells in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two types of human mast cells that have distinct neutral protease compositions.
Irani, A. A., Schechter, N. M., Craig, S. S., DeBlois, G., & Schwartz, L. B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4464 · Cited by 1,005
Interleukin-10 Therapy—Review of a New Approach
Asadullah, K., Sterry, W., & Volk, H. D. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 946
Kovanen, P. T., Kaartinen, M., & Paavonen, T. (1995) · Circulation · doi:10.1161/01.cir.92.5.1084 · Cited by 613
Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2
Molino, M., Barnathan, E. S., Numerof, R., Clark, J., Dreyer, M., Cumashi, A., Hoxie, J. A., Schechter, N., Woolkalis, M., & Brass, L. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4043 · Cited by 591
The incidence and management of infusion reactions to infliximab: a large center experience
Cheifetz, A. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00231-4 · Cited by 491
Induction of Intestinal Inflammation in Mouse by Activation of Proteinase-Activated Receptor-2
Cenac, N., Coelho, A.-M., Nguyen, C., Compton, S., Andrade-Gordon, P., MacNaughton, W. K., Wallace, J. L., Hollenberg, M. D., Bunnett, N. W., Garcia-Villar, R., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64466-5 · Cited by 378
Cairns, J. A., & Walls, A. F. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.275 · Cited by 344
Laine, P., Kaartinen, M., Penttilä, A., Panula, P., Paavonen, T., & Kovanen, P. T. (1999) · Circulation · doi:10.1161/01.cir.99.3.361 · Cited by 342
Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat
Santos, J., Yang, P.-C., Söderholm, J. D., Benjamin, M., & Perdue, M. H. (2001) · Gut · doi:10.1136/gut.48.5.630 · Cited by 313
Crohn's disease: Transmission electron microscopic studies
Dvorak, A. M., Monahan, R. A., Osage, J. E., & Dickersin, G. R. (1980) · Human Pathology · doi:10.1016/s0046-8177(80)80072-4 · Cited by 298
Human skin mast cells: their dispersion, purification, and secretory characterization.
Benyon, R. C., Lowman, M. A., & Church, M. K. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.861 · Cited by 267
Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease
BISCHOFF, S. C., WEDEMEYER, J., HERRMANN, A., MEIER, P. N., TRAUTWEIN, C., CETIN, Y., MASCHEK, H., STOLTE, M., GEBEL, M., & MANNS, M. P. (1996) · Histopathology · doi:10.1046/j.1365-2559.1996.262309.x · Cited by 261
Patella, V., Marinò, I., Arbustini, E., Lamparter-Schummert, B., Verga, L., Adt, M., & Marone, G. (1998) · Circulation · doi:10.1161/01.cir.97.10.971 · Cited by 246
Basophils and Mast Cells: Morphologic Insights into Their Biology, Secretory Patterns, and Function1
Galli, S. J., Dvorak, A. M., & Dvorak, H. F. (2015) · Chemical Immunology and Allergy · doi:10.1159/000408370 · Cited by 238
Guellouz, S., Pariente, B., Benet, C., Baudry, C., Lourenco, N., Kraemer, A., Allez, M., & Gornet, J.-M. (2014) · Case Reports in Gastroenterology · doi:10.1159/000360844 · Cited by 216
He, S., Peng, Q., & Walls, A. F. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.12.6216 · Cited by 215
Self-citationThe human mast cell: functions in physiology and disease
Krishnaswamy, G. (2001) · Frontiers in Bioscience · doi:10.2741/krishnas · Cited by 202
Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
Schechter, N. M., Irani, A. M., Sprows, J. L., Abernethy, J. L., Wintroub, B. U., & Schwartz, L. B. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.8.2652 · Cited by 200
Role of platelet-activating factor in ulcerative colitis
Eliakim, R., Karmeli, F., Razin, E., & Rachmilewitz, D. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90346-0 · Cited by 191
Paradoxical response to heparin in 10 patients with ulcerative colitis.
Gaffney, P. R., Doyle, C. T., Gaffney, A., Hogan, J., Hayes, D. P., & Annis, P. (1995) · PubMed · Cited by 189
Caulfield, J. P., Lewis, R. A., Hein, A., & Austen, K. F. (1980) · The Journal of cell biology · doi:10.1083/jcb.85.2.299 · Cited by 182
Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases
Godfrey, H. P., Ilardi, C., Engber, W., & Graziano, F. M. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270803 · Cited by 172
Gelbmann, C. M., Mestermann, S., Gross, V, Köllinger, M., Schölmerich, J., & Falk, W. (1999) · Gut · doi:10.1136/gut.45.2.210 · Cited by 169
Ajuebor, M. N., Singh, A., & Wallace, J. L. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.1.g238 · Cited by 168
Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation
He, S., & Walls, A. F. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)83033-6 · Cited by 167
Self-citationHe, S., & Walls, A. F. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702223 · Cited by 158
Self-citationMast cells are an important cellular source of tumour necrosis factor α in human intestinal tissue
Bischoff, S. C., Lorentz, A., Schwengberg, S., Weier, G., Raab, R., & Manns, M. P. (1999) · Gut · doi:10.1136/gut.44.5.643 · Cited by 158
Release of Mast Cell Tryptase from Human Colorectal Mucosa in Inflammatory Bowel Disease
Raithel, M., Winterkamp, S., Pacurar, A., Ulrich, P. M., Hochberger, J., & Hahn, E. G. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201750065933 · Cited by 153
Human mast cell carboxypeptidase. Selective localization to MCTC cells
Irani, A. M., Goldstein, S., Wintroub, B. U., Bradford, T. R., & Schwartz, L. B. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.1.247 · Cited by 152
Woolley, D. E., & Tetlow, L. C. (1999) · Arthritis Research & Therapy · doi:10.1186/ar70 · Cited by 152
He, S., Gaça, M., & Walls, A. F. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37586-x · Cited by 151
Self-citationHeterogeneity of human mast cells.
Schulman, E. S., Kagey‐Sobotka, A., MacGlashan, D. W., Adkinson, N. F., Peters, S. P., Schleimer, R. P., & Lichtenstein, L. M. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.4.1936 · Cited by 147
The role of mast cells and basophils in inflammation
Holgate (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00093.x · Cited by 136
Mast Cells in Fibrotic Lung Disorders
Pesci, A., Bertorelli, G., Gabrielli, M., & Olivieri, D. (1993) · CHEST Journal · doi:10.1378/chest.103.4.989 · Cited by 135
Mast cells and inflammatory mediators in chronic ulcerative colitis
Stoyanova, I. I., & Gulubova, M. V. (2002) · Acta Histochemica · doi:10.1078/0065-1281-00641 · Cited by 129
Urinary Excretion of N-Methylhistamine as a Marker of Disease Activity in Inflammatory Bowel Disease
Winterkamp, S., Weidenhiller, M., Otte, P. S., Stolper, J., Schwab, D., Hahn, E. G., & Raithel, M. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.07028.x · Cited by 125
Raithel, M., Matek, M., Baenkler, H. W., Jorde, W., & Hahn, E. G. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000237129 · Cited by 125
Mast cells and immunoglobulin E in inflammatory bowel disease.
Lloyd, G., Green, F. H. Y., Fox, H., Mani, V., & Turnberg, L. A. (1975) · Gut · doi:10.1136/gut.16.11.861 · Cited by 123
Histamine release from gut mast cells from patients with inflammatory bowel diseases.
Nolte, H., Spjeldnaes, N., Kruse, A., & Nielsen, B. W. (1990) · Gut · doi:10.1136/gut.31.7.791 · Cited by 121
The jejunal secretion of histamine is increased in active Crohn's disease
Knutson, L., Ahrenstedt, Ö., Odlind, B., & Hällgren, R. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90006-m · Cited by 121
Histamine: mercurial messenger in the gut
Rangachari, P. K. (1992) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1992.262.1.g1 · Cited by 120
Enhancement of human intestinal mast cell mediator release in active ulcerative colitis
Fox, C. C., Lazenby, A. J., Moore, W. C., et al. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91238-2 · Cited by 117
Atkinson, J. B., Harlan, C. W., Harlan, G., et al. (1994) · Human Pathology · doi:10.1016/0046-8177(94)90271-2 · Cited by 116
Cytokine and Anti-cytokine Therapies for Inflammatory Bowel Disease
Ogata, H., & Hibi∥, T. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033455035 · Cited by 115
Unfractioned Heparin in The Therapy of Patients With Highly Active Inflammatory Bowel Disease
Folwaczny, C., Wiebecke, B., & Loeschke, K. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01143.x · Cited by 114
Scudamore, C. L., Jepson, M. A., Hirst, B. H., Hugh, R., & Miller, P. (1998) · European Journal of Cell Biology · doi:10.1016/s0171-9335(98)80065-4 · Cited by 112
Mast Cell Activation by Mycobacterium tuberculosis : Mediator Release and Role of CD48
Muñoz-Cruz, S., Hernández‐Pando, R., Abraham, S. N., & Enciso, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5590 · Cited by 112
Eosinophil granule proteins activate human heart mast cells
Patella, V., de Crescenzo, G., Marinò, I., Genovese, A., Adt, M., Gleich, G. J., & Marone, G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1219 · Cited by 110
Dvořàk, A. M., McLeod, R. S., Onderdonk, A. B., Monahan-Earley, R. A., Cullen, J., Antonioli, D. A., Morgan, E. S., Blair, J. E., Estrella, P., Cisneros, R. L., et al. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000236338 · Cited by 108
Heparin, cell adhesion, and pathogenesis of inflammatory bow el disease
Day, R. M., & Forbes, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09267-8 · Cited by 107
Mast cell involvement in gastritis with or without Helicobacter pylori infection
Nakajima, S., Krishnan, B., Ota, H., Segura, A., Hattori, T., Dy, G., & Genta, R. M. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70167-7 · Cited by 106
Scheinin, T. M., Butler, D., Salway, F., Scallon, B. J., & Feldmann, M. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02193.x · Cited by 103
Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains
Toms, R., Weiner, H. L., & Johnson, D. K. (1990) · Journal of Neuroimmunology · doi:10.1016/0165-5728(90)90101-r · Cited by 102
Crowe, S. E., Luthra, G. K., & Perdue, M. H. (1997) · Gut · doi:10.1136/gut.41.6.785 · Cited by 97
Expression of Protease-Activated Receptor 2 in Ulcerative Colitis
Kim, J.-A., Choi, S.-C., Yun, K.-J., Kim, D.-K., Han, M.-K., Seo, G.-S., Yeom, J.-J., Kim, T.-H., Nah, Y.-H., & Lee, Y.-M. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200307000-00002 · Cited by 96
Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis
King, T., Biddle, W. L., Bhatia, P. S., Moore, J., & Miner, P. B. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01307568 · Cited by 96
Medical therapy for ulcerative colitis
Jani, N. D., & Regueiro, M. D. (2002) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(01)00010-3 · Cited by 93
The internal pH of mast cell granules
Johnson, R. G., Carty, S. E., Fingerhood, B. J., & Scarpa, A. (1980) · FEBS Letters · doi:10.1016/0014-5793(80)81050-7 · Cited by 93
Tremaine, W., Brzezinski, A., Katz, J. A., Wolf, D. C., Fleming, T., Mordenti, J. J., Strenkoski‐Nix, L. C., Kurth, M., & THE AXYS ULCERATIVE COLITIS STUDY GROUP (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01194.x · Cited by 90
Mast Cells in the Airway Lumen and Bronchial Mucosa of Patients with Chronic Bronchitis
Pesci, A., Rossi, G. A., Bertorelli, G., Aufiero, A., Zanon, P., & Olivieri, D. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.5.8173772 · Cited by 90
Lorentz, A., Schwengberg, S., Mierke, C. T., Manns, M. P., & Bischoff, S. C. (1999) · European Journal of Immunology · Cited by 88
Ang, Y. S., Mahmud, N., White, B., Byrne, M., Kelly, A., Lawler, M., McDonald, G. S. A., Smith, O. P., & Keeling, P. W. N. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00802.x · Cited by 88
Human mast cell carboxypeptidase. Purification and characterization.
Goldstein, S., Kaempfer, C. E., Kealey, J. T., & Wintroub, B. U. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114061 · Cited by 85
Araki, Y., Andoh, A., Fujiyama, Y., & Bamba, T. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01094.x · Cited by 85
Thiothalidomides: Novel Isosteric Analogues of Thalidomide with Enhanced TNF-α Inhibitory Activity
Zhu, X., Giordano, T., Yu, Q.-S., Holloway, H. W., Perry, T., Lahiri, D. K., Brossi, A. R., & Greig, N. H. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030152f · Cited by 83
Crohn's disease: in defense of a microvascular aetiology
THORNTON, M. J., & Solomon, M. J. (2002) · International Journal of Colorectal Disease · doi:10.1007/s00384-002-0408-5 · Cited by 81
Potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease
Papa, A., Danese, S., Gasbarrini, A., & Gasbarrini, A. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00860.x · Cited by 78
Ketotifen effectively prevents mucosal damage in experimental colitis.
Eliakim, R., Karmeli, F., Okon, E., & Rachmilewitz, D. (1992) · Gut · doi:10.1136/gut.33.11.1498 · Cited by 78
Effect of Substance P on Histamine Secretion from Gut Mucosa in Inflammatory Bowel Disease
Raithel, M. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655299750026236 · Cited by 77
Nishida, Y., Murase, K., Isomoto, H., Furusu, H., Mizuta, Y., Riddell, R. H., & Kohno, S. (2002) · PubMed · Cited by 77
Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Terada, T., & Matsunaga, Y. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80129-4 · Cited by 73
Okayama, Y., Benyon, R. C., Lowman, M. A., & Church, M. K. (1994) · Allergy · doi:10.1111/j.1398-9995.1994.tb02657.x · Cited by 72
Mast Cells in Rapidly Progressive Glomerulonephritis
Tóth, T., Tóth-Jakatics, R., Jimi, S., Ihara, M., Urata, H., & Takebayashi, S. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1071498 · Cited by 70
Autocrine regulation of cord blood–derived human mast cell activation by IL-10
Royer, B., Varadaradjalou, S., Saas, P., Gabiot, A.-C., Kantelip, B. M., Féger, F., Guillosson, J., Kantelip, J., & Arock, M. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.115753 · Cited by 69
Delineation of the protective action of zinc sulfate on ulcerative colitis in rats
Luk, H.-H., Ko, J. K.-S., Fung, H.-S., & Cho, C. H. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01592-3 · Cited by 69
(1990) · PubMed · Cited by 68
Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis.
Nakamura, A., Yamazaki, K., Suzuki, K., & SATO, S. (1997) · PubMed · Cited by 68
Hunt, L. W., Colby, T. V., Weiler, D. A., Sur, S., & Butterfield, J. H. (1992) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60924-0 · Cited by 67
Activation of ion secretion via proteinase-activated receptor-2 in human colon
Mall, M. A., Gonska, T. Y., Thomas, J., Hirtz, S., Schreiber, R., & Kunzelmann, K. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00137.2001 · Cited by 67
He, S., Gaça, M., McEuen, A. R., & Walls, A. F. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35133-x · Cited by 65
Self-citationCorticosteroid treatment reduces mast cell numbers in inflammatory bowel disease
Goldsmith, P., McGarity, B. H., Walls, A. F., et al. (1990) · Digestive Diseases and Sciences · doi:10.1007/bf01536749 · Cited by 64
MAST CELLS IN THE SYNOVIUM AND SYNOVIAL FLUID IN OSTEOARTHRHIS
Dean, G. A., Hoyland, J. A., Denton, J., Donn, R. P., & Freemont, A. J. (1993) · Rheumatology · doi:10.1093/rheumatology/32.8.671 · Cited by 64
Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease
Middel, P., Reich, K., Polzien, F., et al. (2001) · Gut · doi:10.1136/gut.49.6.795 · Cited by 64
Stromal Mast Cells and Nerve Fibers in Various Chronic Liver Diseases: Relevance To Hepatic Fibrosis
Matsunaga, Y., Kawasaki, H., & Terada, T. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01232.x · Cited by 63
The induction of a prolonged increase in microvascular permeability by human mast cell chymase
He, S., & Walls, A. F. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00343-4 · Cited by 61
Self-citationElevated Histamine and Tryptase Levels in Smokers’ Bronchoalveolar Lavage Fluid
Kalenderian, R., Linga, R., Roth, W., Schwartz, L. B., Gruber, B. L., & Janoff, A. (1988) · CHEST Journal · doi:10.1378/chest.94.1.119 · Cited by 61
Fox, C. C., Moore, W. C., & Lichtenstein, L. M. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01300753 · Cited by 60
Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients.
Sobhani, I., Hochlaf, S., Denizot, Y., Vissuzaine, C., René, E., Benveniste, J., Lewin, M., & Mignon, M. (1992) · Gut · doi:10.1136/gut.33.9.1220 · Cited by 59
Dotan, I., Hallak, A., Arber, N., Santo, M., Alexandrowitz, A., Knaani, Y., Hershkoviz, R., Brazowski, E., & Halpern, Z. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1011979418914 · Cited by 58
Tryptase: potential role in airway inflammation and remodeling
Abraham, W. M. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00429.2001 · Cited by 58
Tumor Necrosis Factor-Alpha in Ileal Mast Cells in Patients with Crohn’s Disease
Lilja, I., Gustafson‐Svärd, C., Franzén, L., et al. (2000) · Digestion · doi:10.1159/000007737 · Cited by 57
Vrij, A. A., Jansen, J. M., Schoon, E. J., de Bruïne, A. P., Hemker, H. C., & Stockbrügger, R. W. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201753265091 · Cited by 56
He, S., McEuen, A. R., Blewett, S. A., Li, P., Buckley, M. G., Leufkens, P., & Walls, A. F. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01651-9 · Cited by 55
Self-citationFox, C. C., Lichtenstein, L. M., & Roche, J. K. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01295728 · Cited by 55
Ion Transport Induced by Proteinase-Activated Receptors (PAR2) in Colon and Airways
Kunzelmann, K., Schreiber, R., König, J. C., et al. (2002) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:36:2-3:209 · Cited by 49
Mast cells in ulcerative colitis
Balázs, M., Íllyés, G., & Vadász, G. (1989) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02899101 · Cited by 49
Meier, H. L., Heck, L. W., Schulman, E. S., & MacGlashan, D. W. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000233779 · Cited by 48
Increased cardiac mast cell density and mediator release in patients with dilated cardiomyopathy
Patella, V., de Crescenzo, G., & Lamparter-Schummert, B. (1997) · Inflammation Research · doi:10.1007/s000110050041 · Cited by 47
Chymase-positive mast cells in small sized adenocarcinoma of the lung
Nagata, M., Shijubo, N., Walls, A. F., Ichimiya, S., Abe, S., & Sato, N. (2003) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-003-0842-y · Cited by 46
Robinson, C., Benyon, R. C., Holgate, S. T., & Church, M. K. (1989) · Journal of Investigative Dermatology · doi:10.1016/0022-202x(89)90066-3 · Cited by 44
The effect of heparin on trinitrobenzene sulphonic acid‐induced colitis in the rat
Fries, W., Pagiaro, Canova, Carraro, Gasparini, Pomerri, Martin, Carlotto, Mazzon, E., Sturniolo, et al. (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00293.x · Cited by 43
Evidence for control of mast cell granule protease in situ by low pH*1
Lagunoff, D. (1983) · Experimental Cell Research · doi:10.1016/0014-4827(83)90414-7 · Cited by 43
Ketotifen Therapy for Acute Ulcerative Colitis in Children (A Pilot Study)
Jones, N. L., Roifman, C. M., Griffiths, A. M., & Sherman, P. M. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018827527826 · Cited by 42
Traynor, T. R., Brown, D. R., & O’Grady, S. M. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10303-0 · Cited by 42
McEuen, A. R., He, S., Brander, M. L., & Walls, A. F. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00211-0 · Cited by 40
Self-citationMast Cells in Bronchiolitis Obliterans Organizing Pneumonia
Pesci, A., Majori, M., Piccoli, M. L., Casalini, A. G., Curti, A., Franchini, D., & Gabrielli, M. (1996) · CHEST Journal · doi:10.1378/chest.110.2.383 · Cited by 40
Fargeas, M. J., Theodorou, V., More, J., Wal, J. M., Fioramonti, J., & Bueno, L. P. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90268-6 · Cited by 39
He, S., Gaça, M., & Walls, A. F. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00734-8 · Cited by 38
Self-citationMast Cell Basic Fibroblast Growth Factor in Silicosis
Hamada, H., Vallyathan, V., Cool, C. D., BARKER, E., Inoue, Y., & Newman, L. S. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.6.9812132 · Cited by 38
Bradding, P., Walls, A. F., & Church, M. K. (1995) · Elsevier eBooks · doi:10.1016/b978-012352325-9/50006-x · Cited by 37
Eliakim, R., Karmeli, F., Cohen, P., Heyman, S. N., & Rachmilewitz, D. (2001) · International Journal of Colorectal Disease · doi:10.1007/s003840000262 · Cited by 36
Roles of the mast cell and basophil in asthma
Walls, A. F., He, S., Buckley, M. G., & McEuen, A. R. (2001) · Clinical & Experimental Allergy Reviews · doi:10.1046/j.1472-9725.2001.00009.x · Cited by 35
Self-citationCellular and molecular characteristics of inflammation in chronic bronchitis
Sun, Stacey, Vittori, Marini, Bellini, Kleimberg, & Mattoli (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00285.x · Cited by 35
Ketotifen Treatment of Active Colitis in Patients with 5‐Aminosalicylate Intolerance
Marshall, J. K., & Irvine, E. J. (1998) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/1998/398142 · Cited by 34
Tsuneyama, K., Saito, K., Ruebner, B. H., KONISHI, I., Nakanuma, Y., & Gershwin, M. E. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005429130150 · Cited by 33
Toda, S., Tokuda, Y., Koike, N., Yonemitsu, N., Watanabe, K. S., Koike, K., Fujitani, N., Hiromatsu, Y., & Sugihara, H. (2000) · Thyroid · doi:10.1089/thy.2000.10.381 · Cited by 32
Effect of Drugs on Colonic Eicosanoid Accumulation in Active Ulcerative Colitis
Eliakim, R., Karmeli, F., Chorev, M., Okon, E., & Rachmilewitz, D. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209000172 · Cited by 32
Inflammatory bowel disease: sorting out the treatment options.
Wolf, J. M., & Lashner, B. A. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.8.621 · Cited by 32
Kurusu, A., Suzuki, Y., Horikoshi, S., Shirato, I., & Tomino, Y. (2001) · The Nephron journals/Nephron journals · doi:10.1159/000046109 · Cited by 31
Activation of human colon mast cells through proteinase activated receptor-2
He, S., He, Y.-S., & Xie, H. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i3.327 · Cited by 30
Self-citationFurusu, H., Murase, K., NISHIDA, Y., Isomoto, H., Takeshima, F., Mizuta, Y., Hewlett, B. R., Rh, R., & KOHNO, S. (2002) · PubMed · Cited by 26
Zimnoch, L., SZYNAKA, B., & Puchalski, Z. (2002) · PubMed · Cited by 26
McKenna, M. J. (1994) · Calcified Tissue International · doi:10.1007/bf00310402 · Cited by 25
Is nitric oxide and heparin treatment justified in inflammatory bowel disease? An experimental study
Dobosz, M., Mionskowska, L., Dobrowolski, S., Dymecki, D., Makarewicz, W., Hrabowska, M., & Wajda, Z. (1996) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519609090602 · Cited by 24
Weidenhiller, M., Raithel, M., Winterkamp, S., Otte, P. S., Stolper, J., & Hahn, E. G. (2000) · Inflammation Research · doi:10.1007/pl00000171 · Cited by 23
Monocytes or T cells in Crohn's disease: does IL-16 allow both to play at that game?
Schreiber, S. (2001) · Gut · doi:10.1136/gut.49.6.747 · Cited by 22
Regulation of ion transport by histamine in mouse cecum
Homaidan, F. R., Tripodi, J., Zhao, L., & Burakoff, R. B. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00184-2 · Cited by 21
Platelet-Activating Factor–A Possible Mediator in the Pathogenesis of Ulcerative Colitis
Rachmilewitz, D., Karmeli, F., & Eliakim, R. (1990) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529009091904 · Cited by 19
Medical therapies for ulcerative colitis and crohn’s disease
Baert, F. J., & Rutgeerts, P. J. (2000) · Current Gastroenterology Reports · doi:10.1007/s11894-000-0006-z · Cited by 18
Crivellato, E., Finato, N., Isola, M., Ribatti, D., & Beltrami, C. A. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01182.x · Cited by 18
Witzens‐Harig, M., Moehler, T. M., Neben, K., Früehauf, S., Hartschuh, W., Ho, A. D., & Goldschmidt, H. (2004) · Annals of Hematology · doi:10.1007/s00277-003-0804-0 · Cited by 18
Modulation of tryptase secretion from human colon mast cells by histamine
He, S., & Xie, H. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i3.323 · Cited by 15
Self-citationRiehl, T. E., & Stenson, W. F. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90749-1 · Cited by 14
Ligumsky, M., Kuperstein, V., Nechushtan, H., Zhang, Z., & Razin, E. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00933-2 · Cited by 14
Modulation of histamine release from human colon mast cells by protease inhibitors
He, S., & Xie, H. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i3.337 · Cited by 13
Self-citationPharmacological Study of Stem-Cell-Factor-Induced Mast Cell Histamine Release with Kinase Inhibitors
Nagai, S., Kitani, S., Hirai, K., Takaishi, T., Nakajima, K., Kihara, H., Nonomura, Y., Ito, K., & Morita, Y. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1377 · Cited by 13
Inhibition of tryptase release from human colon mast cells by protease inhibitors
He, S., & Xie, H. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i3.332 · Cited by 13
Self-citationAmano, H., Kurosawa, M., Ishikawa, O., Chihara, J., & Miyachi, Y. (2000) · Journal of Dermatological Science · doi:10.1016/s0923-1811(00)00085-2 · Cited by 12
Sepper, R., Konttinen, Y. T., Kemppinen, P., Sorsa, T. A., & Eklund, K. K. (1998) · Annals of Medicine · doi:10.3109/07853899809005860 · Cited by 12
Bs, T., & Edwards, W. D. (1988) · The American journal of cardiovascular pathology · Cited by 11
Cloning and expression of human colon mast cell carboxypeptidase
Chen, Z., & He, S. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i3.342 · Cited by 10
Self-citationMcCarty, M. F. (1998) · Medical Hypotheses · doi:10.1016/s0306-9877(98)90247-x · Cited by 8
Influence ofHelicobacter pylori on tryptase and cathepsin D in peptic ulcer
Plebani, M., Basso, D., Rugge, M., Vianello, F., & Mario, F. D. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02063258 · Cited by 8
Cited by
Interleukin-1 (IL-1): A central regulator of stress responses
Goshen, I., & Yirmiya, R. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.10.001 · Cited by 399
Regulation of the immune response and inflammation by histamine and histamine receptors
O’Mahony, L., Akdis, M., & Akdis, C. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.06.051 · Cited by 313
The role of mast cells in functional GI disorders
Wouters, M. M., Vicario, M., & Santos, J. (2016) · Gut · doi:10.1136/gutjnl-2015-309151 · Cited by 308
Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors
Kurashima, Y., Amiya, T., Nochi, T., Fujisawa, K., Haraguchi, T., Iba, H., Tsutsui, H., Sato, S., Nakajima, S., Iijima, H., et al. (2012) · Nature Communications · doi:10.1038/ncomms2023 · Cited by 286
Keita, Å. V., & Söderholm, J. D. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01498.x · Cited by 286
Metadata
- Authors
- He, S.-H.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2004
- Volume
- 10
- Issue
- 3
- Pages
- 309
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W65678198
- Cited by
- 263
- References
- 144
- FWCI
- 5.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.